Mice with MIF deletion are protected from immune-mediated lupus nephritis and treatment with a neutralizing anti-MIF antibody ameliorates kidney injury in crescentic anti-GBM glomerulonephritis [43,44]. Here, MIF is linked to glioblastoma.